MELBOURNE, Australia, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Imprivata, a leading provider of access management solutions for healthcare and other mission-critical…
TAIPEI, Aug. 4, 2025 /PRNewswire/ -- Anbogen Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has approved…
EVANSVILLE, Ind.--(BUSINESS WIRE)--This updated release corrects the previously reported lot codes included in the press release dated July 10, 2025.…